JANX | Janux Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	26.65 - 28.28
52 Week Range	26.65 - 71.71
Beta	3.14
Implied Volatility	81.13%
IV Rank	23.91%
Day's Volume	163,353
Average Volume	959,979
Shares Outstanding	59,105,200
Market Cap	1,615,049,590
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-06-11

Valuation
Profitability
Growth
Health
P/E Ratio	-21.35
Forward P/E Ratio	N/A
EPS	-1.28
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	76
Country	USA
Website	JANX

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.

JANX's peers: ADAG, FENC, GHRS, GNFT, GNTA, HRMY, IMTX, INSM, IVA, MLYS, ELYM, ANEB, RZLT, KROS, EWTX, MOLN, MNOV, CSBR, CYT, AVTE, ACRV, ANTX, PHAR, PHVS, PRTC, PRTG, SLGL, NAMS, MLEC

*Chart delayed

Analyzing fundamentals for JANX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see JANX Fundamentals page.

Watching at JANX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on JANX Technicals page.